Editas Medicine: A Risk/Reward Worth Considering
Editas Medicine(EDIT) Seeking Alpha·2024-09-25 23:46
Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial. It has been about eight months since my previous Editas Medicine (NASDAQ: EDIT ) article , where I discussed the company's efforts to focus on their three key pillars of advancing reni-cel, progressing their invivo editing pipeline, and expanding busine ...